Series A Investors & VC Firms in United Kingdom

433 firms in this list, with a median first check of $504K. 32 of them lead rounds. Generated from verified public data and updated continuously.

Fund	FoxScore	HQ	Invests	Stage	Check	CRM
CL Clean Growth Fund AGBGJTSM9 people	88🔒	London	GB	Seed–Series A	$635K – $3.8M	+ Add to CRM
DE Development Bank of Wales BCCRCGMO9 people	88🔒	Cardiff	GB	Pre-Seed–Late Stage	$12.7K – $12.7M	+ Add to CRM
DS dsm-firmenich Venturing SHAKADAM9 people	88🔒	Maastricht	NL	Pre-Seed–Late Stage	$108K – $5.4M	+ Add to CRM
IM Imaginary Venture Capital NMNBKDLL9 people	88🔒	New York	US	Seed–Late Stage	$1M – $10M	+ Add to CRM
MO Move Energy FDFBLRMT9 people	88🔒	Amsterdam	NL	Seed–Series B	$2.7M – $5.4M	+ Add to CRM
NI Niya Partners ADAAAJBS6 people	88🔒	Dubai	US	Seed–Growth	—	+ Add to CRM
PM PM Equity Partner AGACCODS9 people	88🔒	Lausanne	CH	Series A–Series B	$2M – $50M	+ Add to CRM
RE REV Venture Partners KBTADN3 people	88🔒	San Francisco	US	Seed–Late Stage	$1M – $10M	+ Add to CRM
SH Ship2B Ventures MFMRXPJD9 people	88🔒	Barcelona	ES	Seed–Series A	$216K – $2.2M	+ Add to CRM
BP bp ventures CBKRSNCS8 people	88🔒	London	GB	Seed–Series A	$1M – $10M	+ Add to CRM
ED EDB Investments CKCLCGJO11 people	88🔒	—	SG	Seed–Series B	—	+ Add to CRM
LA LAUNCHub Ventures LBTBIDRI8 people	88🔒	Sofia	BG	Pre-Seed–Series A	$324K – $3.2M	+ Add to CRM
WE WEEKEND RHVJ2 people · Follows rounds	88🔒	Miami	US	Pre-Seed–Late Stage	$100K – $300K	+ Add to CRM
6 6 Degrees Capital FCLSTDTO8 people	88🔒	London	BE	Seed–Series B	$1.1M – $5.4M	+ Add to CRM
AN Anthemis Venture ANSPAGED11 people	88🔒	New York	US	Seed–Late Stage	—	+ Add to CRM
AP Apollo Health Ventures NROMABJA11 people	88🔒	Berlin	DE	Seed–Series A	—	+ Add to CRM
CA Calculus Capital Ltd. JGSMEKNE11 people	88🔒	London	GB	Seed–Late Stage	$2.5M	+ Add to CRM
EU Eurazeo AACMESEL11 people	88🔒	Paris	FR	Series A–Late Stage	—	+ Add to CRM
HE HealthCap AVAFBOCK11 people	88🔒	Stockholm	SE	Seed–Series A	—	+ Add to CRM
IS Isomer Capital CWJSTSCD11 people	88🔒	London	GB	Seed–Late Stage	—	+ Add to CRM
LI Lingfeng Capital MMNRMSNM5 people	88🔒	Beijing	CN	Seed–Series B	—	+ Add to CRM
NO Nordic Eye Venture Capital MTAKCTID11 people	88🔒	Copenhagen K	DK	Seed–Series A	—	+ Add to CRM
OL Oltre Impact LALBNLRF8 people	88🔒	Milan	IT	Series A–Late Stage	$2.2M – $8.6M	+ Add to CRM
PA Panakes Partners ABDSFLBC11 people	88🔒	Milan	IT	Seed–Late Stage	—	+ Add to CRM

Clean Growth Fund

LondonSeed–Series A$635K – $3.8M

AGBGJTSM9 people

Development Bank of Wales

CardiffPre-Seed–Late Stage$12.7K – $12.7M

BCCRCGMO9 people

dsm-firmenich Venturing

MaastrichtPre-Seed–Late Stage$108K – $5.4M

SHAKADAM9 people

Imaginary Venture Capital

New YorkSeed–Late Stage$1M – $10M

NMNBKDLL9 people

Move Energy

AmsterdamSeed–Series B$2.7M – $5.4M

FDFBLRMT9 people

Niya Partners

DubaiSeed–Growth

ADAAAJBS6 people

PM Equity Partner

LausanneSeries A–Series B$2M – $50M

AGACCODS9 people

REV Venture Partners

San FranciscoSeed–Late Stage$1M – $10M

KBTADN3 people

Ship2B Ventures

BarcelonaSeed–Series A$216K – $2.2M

MFMRXPJD9 people

bp ventures

LondonSeed–Series A$1M – $10M

CBKRSNCS8 people

EDB Investments

Seed–Series B

CKCLCGJO11 people

LAUNCHub Ventures

SofiaPre-Seed–Series A$324K – $3.2M

LBTBIDRI8 people

WEEKEND

MiamiPre-Seed–Late Stage$100K – $300K

RHVJ2 people

6 Degrees Capital

LondonSeed–Series B$1.1M – $5.4M

FCLSTDTO8 people

Anthemis Venture

New YorkSeed–Late Stage

ANSPAGED11 people

Apollo Health Ventures

BerlinSeed–Series A

NROMABJA11 people

Calculus Capital Ltd.

LondonSeed–Late Stage$2.5M

JGSMEKNE11 people

Eurazeo

ParisSeries A–Late Stage

AACMESEL11 people

HealthCap

StockholmSeed–Series A

AVAFBOCK11 people

Isomer Capital

LondonSeed–Late Stage

CWJSTSCD11 people

Lingfeng Capital

BeijingSeed–Series B

MMNRMSNM5 people

Nordic Eye Venture Capital

Copenhagen KSeed–Series A

MTAKCTID11 people

Oltre Impact

MilanSeries A–Late Stage$2.2M – $8.6M

LALBNLRF8 people

Panakes Partners

MilanSeed–Late Stage

ABDSFLBC11 people

Data sourced from public filings and firms' own websites — see our methodology.